Fri news: FDA outlines accelerated review guidelines. Teva divests its Japan venture. DualityBio/BioNTech ADC data. Learning from 2024 biotech IPOs. Trump’s proposed tariffs and generic drugs. —http://bit.ly/w28kSd
Cafepharma
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.
cafepharma